Skip to main content
Log in

Genotyping cost effective prior to allopurinol treatment

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 US dollars

  2. urate-lowering agent

Reference

  • Ke CH, et al. Cost-effectiveness Analysis for Genotyping before Allopurinol Treatment to Prevent Severe Cutaneous Adverse Drug Reactions. The Journal of Rheumatology : Apr 2017. Available from: URL: http://doi.org/10.3899/jrheum.151476

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Genotyping cost effective prior to allopurinol treatment. PharmacoEcon Outcomes News 776, 20 (2017). https://doi.org/10.1007/s40274-017-3922-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3922-y

Navigation